Regulatory approvals from FDA and EUA and growing investment and policy support from governments worldwide forecast a bright outlook for the biotech industry in the long run.

Liana Moussatos of Wedbush Securities doesn't wait for the catalyst to strike. She, like other successful investors, picks her targets and takes profits earlier, while less sophisticated investors wait for the press releases.

Details on the latest insider buys: EOG Resources, Opko Health, Jabil Circuit, Seneca Foods, Gulfmark Offshore, and latest sells: Facebook, Cheniere Energy, United Therapeutics Corporation, SL Green Realty, and G-III Apparel.

Insider buying decreased with insiders purchasing $137.24 million of their stock last week compared to $144.43 million in the week prior. Selling also decreased with insiders selling $1.06 billion of stock last week compared to $2.32 billion in the week prior.

Our weekly best and worst report shows you stocks with the best potential returns over the coming 6 to 12 months.